Overview

• Demis Hassabis, CEO of Google DeepMind, predicts AI could lead to the 'end of disease' within the next ten years, transforming healthcare globally.
• Hassabis claims AI can reduce drug development timelines from 10 years to weeks, cutting costs significantly and accelerating scientific breakthroughs.
• DeepMind's AI has mapped 200 million protein structures, a feat Hassabis equates to one billion years of PhD work completed in a single year.
• The exponential growth of AI, driven by increased attention, funding, and talent, underpins these advancements but also raises concerns about governance and alignment.
• Perplexity AI CEO Aravind Srinivas endorses Hassabis' vision, calling him a 'genius' and advocating for maximum resources to realize these transformative goals.